IMAX China (1970) H1 2024 earnings summary

Executive summary

• Revenue for 1HFY2024 was US$43.9 million, down 3.1% year-over-year, mainly due to a 34.5% drop in Content Solutions revenue, partially offset by a 10.4% increase in Technology Products and Services revenue.

• Net profit for the period was US$12.6 million, down 8.9% year-over-year, with adjusted profit at US$13.4 million (down from US$15.1 million).

• Gross profit decreased 12.5% to US$25.1 million, and gross margin fell from 63.3% to 57.2%.

• No interim dividend was declared for the period.

• The prior year benefited from a record Chinese New Year box office and post-pandemic reopening, which was not repeated in 2024.

Financial highlights

• Content Solutions revenue fell to US$9.3 million, driven by a 35% decline in IMAX box office revenue, which was US$107.5 million versus US$165.2 million in 1HFY2023.

• Technology Products and Services revenue rose to US$34.1 million, with strong growth in sales and sales-type lease arrangements (up 82.7% to US$13.7 million) and maintenance revenue (up 17.3% to US$12.9 million).

• Cost of sales increased 13.3% to US$18.8 million, mainly due to higher costs in Technology Products and Services.

• Cash and cash equivalents increased to US$77.5 million from US$62.7 million at year-end 2023.

• Net cash from operating activities was US$19.7 million, up from US$12.0 million in 1HFY2023.

Outlook and guidance

• The company plans to continue upgrading and expanding the IMAX theatre network, focusing capital expenditures on revenue sharing arrangements and executing on its contractual backlog.

• Management expects continued network expansion and higher system installations in 2024, supported by a strong film slate and strategic partnerships.

• The company remains focused on international growth, especially in India, the Middle East, and Southeast Asia.